Division of Pediatric Hematology and Oncology

Cancer centers nationwide join to address the impact of COVID-19 pandemic on cancer prevention and treatment

A consortium of 17 cancer centers in the United States, including Vanderbilt-Ingram Cancer Center, have come together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention.

Post-transplant complication

Vanderbilt researchers conducted the largest analysis to date of a heart complication in children following stem cell transplant. The findings may help guide screening practices to improve outcomes.

Racial Equity Task Force co-chairs named

Three co-chairs have been named to lead a new Racial Equity Task Force, which is charged with identifying barriers to and opportunities for achieving racial equity at Vanderbilt University Medical Center and Vanderbilt University School of Medicine (VUSM).

Friedman named associate director for Community Science and Health Outcomes at Vanderbilt-Ingram Cancer Center

Debra Friedman, MD, MS, E. Bronson Ingram Chair of Pediatric Oncology, is expanding her leadership role in improving cancer outcomes both within and beyond the Vanderbilt-Ingram Cancer Center (VICC) catchment area. She has been named associate director of Community Science and Health Outcomes.

New telehealth initiative aims to enhance cancer care in rural areas

VUMC is leading an effort to improve cancer care in rural areas with a telehealth initiative supported with a $3.3 million grant from the National Cancer Institute.

DeBaun’s mentoring honored by American Society of Hematology

Michael DeBaun, MD, MPH, has been awarded the American Society of Hematology’s 2019 ASH Mentor Award for his sustained and outstanding commitment to the training and career development of early career hematologists.

1 2 3 4